Table 1.
Clinical information of 375 COPD patients.
| Totality | COPD + anxiety/depression | COPD | ||
|---|---|---|---|---|
| Clinical indicators | (n = 375) | (n = 308) | (n = 67) | p Value |
| Gender | .179 | |||
| Female | 88 (23.5%) | 77 (25.0%) | 11 (16.4%) | |
| Male | 287 (76.5%) | 231 (75.0%) | 56 (83.6%) | |
| Age (years) | .031 | |||
| 11 (2.9%) | 11 (3.6%) | 0 (0.0%) | ||
| <70 | 57 (15.2%) | 42 (13.6%) | 15 (22.4%) | |
| ≥90 | 31 (8.3%) | 30 (9.7%) | 1 (1.5%) | |
| 70–80 | 116 (30.9%) | 93 (30.2%) | 23 (34.3%) | |
| 80–90 | 160 (42.7%) | 132 (42.9%) | 28 (41.8%) | |
| Marital status | .452 | |||
| Death of a spouse | 24 (6.4%) | 19 (6.2%) | 5 (7.5%) | |
| Married/de facto married | 348 (92.8%) | 287 (93.2%) | 61 (91.0%) | |
| Single/divorce | 3 (0.8%) | 2 (0.6%) | 1 (1.5%) | |
| Education level | .454 | |||
| High school/technical secondary school | 53 (14.1%) | 44 (14.3%) | 9 (13.4%) | |
| Junior high school | 78 (20.8%) | 68 (22.1%) | 10 (14.9%) | |
| Primary school/no primary school education | 193 (51.5%) | 153 (49.7%) | 40 (59.7%) | |
| College or above | 51 (13.6%) | 43 (14.0%) | 8 (11.9%) | |
| Long-term residence | .069 | |||
| 1 (0.3%) | 1 (0.3%) | 0 (0.0%) | ||
| Country | 345 (92.0%) | 279 (90.6%) | 66 (98.5%) | |
| Cities/towns | 29 (7.7%) | 28 (9.1%) | 1 (1.5%) | |
| Per capita annual household income (RMB) | .321 | |||
| 20,001–30,000 | 5 (1.3%) | 5 (1.6%) | 0 (0.0%) | |
| 30,001–40,000 | 37 (9.9%) | 33 (10.7%) | 4 (6.0%) | |
| 40,001–50,000 | 189 (50.4%) | 149 (48.4%) | 40 (59.7%) | |
| ≥50,001 | 144 (38.4%) | 121 (39.3%) | 23 (34.3%) | |
| Direct economic costs of treating COPD in the past year (RMB) | .359 | |||
| ≤3000 | 226 (60.3%) | 190 (61.7%) | 36 (53.7%) | |
| 3001–6000 | 114 (30.4%) | 91 (29.5%) | 23 (34.3%) | |
| 6001–9000 | 16 (4.3%) | 11 (3.6%) | 5 (7.5%) | |
| ≥9001 | 19 (5.1%) | 16 (5.2%) | 3 (4.5%) | |
| Smoking | .004 | |||
| No | 202 (53.9%) | 177 (57.5%) | 25 (37.3%) | |
| Yes | 173 (46.1%) | 131 (42.5%) | 42 (62.7%) | |
| COPD progression (years) | .077 | |||
| 1 (0.3%) | 0 (0.0%) | 1 (1.5%) | ||
| >15 | 149 (39.7%) | 126 (40.9%) | 23 (34.3%) | |
| 0–5 | 84 (22.4%) | 66 (21.4%) | 18 (26.9%) | |
| 10–15 | 56 (14.9%) | 42 (13.6%) | 14 (20.9%) | |
| 5–10 | 85 (22.7%) | 74 (24.0%) | 11 (16.4%) | |
| Number of acute exacerbation of COPD in the last year (times) | .817 | |||
| 9 (2.4%) | 7 (2.3%) | 2 (3.0%) | ||
| <2 | 253 (67.5%) | 207 (67.2%) | 46 (68.7%) | |
| ≥2 | 113 (30.1%) | 94 (30.5%) | 19 (28.4%) | |
| Regular treatment with inhalants | .359 | |||
| No | 261 (69.6%) | 218 (70.8%) | 43 (64.2%) | |
| Yes | 114 (30.4%) | 90 (29.2%) | 24 (35.8%) | |
| Home oxygen therapy | .985 | |||
| No | 344 (91.7%) | 282 (91.6%) | 62 (92.5%) | |
| Yes | 31 (8.3%) | 26 (8.4%) | 5 (7.5%) | |
| Payment method of medical expenses | .011 | |||
| Public expense | 34 (9.1%) | 33 (10.7%) | 1 (1.5%) | |
| New rural cooperative medical system | 10 (2.7%) | 10 (3.2%) | 0 (0.0%) | |
| Health insurance | 315 (84.0%) | 254 (82.5%) | 61 (91.0%) | |
| Self-paying | 16 (4.3%) | 11 (3.6%) | 5 (7.5%) |
RMB: renminbi.